Syndromes of telomere shortening

Annual Review of Genomics and Human Genetics

Volumn 10, Issue , 2009, Pages 45-61

  Armanios, Mary ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cryptogenic liver cirrhosis; Dyskerin; Interstitial lung disease; Shelterin; Stem cell

Indexed keywords

TELOMERASE;

APLASTIC ANEMIA; AUTOSOMAL DOMINANT INHERITANCE; BONE MARROW DEPRESSION; CANCER SUSCEPTIBILITY; CELL DIVISION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME MUTATION; CHROMOSOME SIZE; CLINICAL DECISION MAKING; CLINICAL FEATURE; DISEASE SEVERITY; DYSKERATOSIS CONGENITA; FIBROSING ALVEOLITIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEMATOPOIETIC STEM CELL; HUMAN; KNOCKOUT MOUSE; LIVER FAILURE; LUNG INSUFFICIENCY; NONHUMAN; ONSET AGE; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; TELOMERE;

ANIMALS; DYSKERATOSIS CONGENITA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PULMONARY FIBROSIS; SYNDROME; TELOMERASE; TELOMERE;

EID: 67650079362     PISSN: 15278204     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-genom-082908-150046     Document Type: Review

References (90)

1. Am. Thorac. Soc./Eur. Respir. Soc. Int. Multidiscip. Consensus Classific. Idiopathic Interstitial Pneumonias. 2002. Joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 165:277-304 (adopted by the ATS board of directors, June 2001, and by the ERS Executive Committee, June 2001)
2. Alder JK, Chen JJ, Lancaster L, Danoff S, Su SC, et al. 2008. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 105:13051-13056
3. Allsopp RC, Morin GB, DePinho R, Harley CB, Weissman IL. 2003. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 102:517-520 (Pubitemid 36841969)
4. Alter BP. 2007. Diagnosis, genetics, and management of inherited bone marrow failure syndromes. Hematol. Am. Soc. Hematol. Educ. Program. 2007:29-39
5. Alter BP, Giri N, Savage SA, Rosenberg PS. 2009. Cancer in dyskeratosis congenita. Blood 113:6549-6557
6. Armanios M, Chen JL, Chang YP, Brodsky RA, Hawkins A, et al. 2005. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl. Acad. Sci. USA 102:15960-15964 (Pubitemid 41552850)
7. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, et al. 2007. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356:1317-1326 (Pubitemid 46513297)
8. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, et al. 2000. Telomere dysfunction promotes nonreciprocal translocations and epithelial cancers in mice. Nature 406:641-645 (Pubitemid 30641052)
9. Aubert G, Lansdorp PM. 2008. Telomeres and aging. Physiol. Rev. 88:557-579
10. Blackburn EH, Greider CW, Szostak JW. 2006.Telomeres and telomerase: the path from maize,Tetrahymena and yeast to human cancer and aging. Nat. Med. 12:1133-1138 (Pubitemid 44527346)
11. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, et al. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34 (Pubitemid 27431310)
12. Campisi J, d'Adda di Fagagna F. 2007. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8:729-740
13. Chen JL, Blasco MA, Greider CW. 2000. Secondary structure of vertebrate telomerase RNA. Cell 100:503-514
14. Chen JL, Greider CW. 2004. Telomerase RNA structure and function: implications for dyskeratosis congenita. Trends Biochem. Sci. 29:183-192 (Pubitemid 38472023)
15. Choudhury AR, Ju Z, Djojosubroto MW, Schienke A, Lechel A, et al. 2007. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat. Genet. 39:99-105 (Pubitemid 46026508)
16. Cronkhite JT, Xing C, Raghu G, Chin KM, Torres F, et al. 2008. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 178:729-737
17. de la Fuente J, Dokal I. 2007. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation. Pediatr. Transplant. 11:584-594 (Pubitemid 47174390)
18. Decatur WA, Fournier MJ. 2002. rRNA modifications and ribosome function. Trends Biochem. Sci. 27:344-351
19. Dokal I, Vulliamy T. 2003. Dyskeratosis congenita: its link to telomerase and aplastic anaemia. Blood Rev. 17:217-225 (Pubitemid 37356392)
20. Du HY, Pumbo E, Ivanovich J, An P, Maziarz RT, et al. 2009. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood 113(2):309-316
21. Erdmann N, Liu Y, Harrington L. 2004. Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice. Proc. Natl. Acad. Sci. USA 101:6080-6085 (Pubitemid 38520531)
22. Feldser DM, Greider CW. 2007. Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 11:461-469
23. Feldser DM, Hackett JA, Greider CW. 2003. Telomere dysfunction and the initiation of genome instability. Nat. Rev. Cancer 3:623-627
24. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, et al. 1995. The RNA component of human telomerase. Science 269:1236-1241
25. Fogarty PF, Yamaguchi H, Wiestner A, Baerlocher GM, Sloand E, et al. 2003. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet 362:1628-1630 (Pubitemid 37443532)
26. Goldman F, Bouarich R, Kulkarni S, Freeman S, Du HY, et al. 2005. The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc. Natl. Acad. Sci. USA 102:17119-17124 (Pubitemid 41692693)
27. Greider CW. 1998. Telomeres and senescence: the history, the experiment, the future. Curr. Biol. 8:R178-81
28. Greider CW. 2006. Telomerase RNA levels limit the telomere length equilibrium. Cold Spring Harbor Symp. Quant. Biol. 71:225-229
29. Greider CW, Blackburn EH. 1985. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43:405-413
30. Greider CW, Blackburn EH. 1987. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51:887-898
31. Greider CW, Blackburn EH. 1989. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337:331-337
32. Greider CW, Blackburn EH. 2004. Tracking telomerase. Cell 116:S83-6, 1 p following S6
33. Hao LY, Armanios M, Strong MA, Karim B, Feldser DM,et al. 2005. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123:1121-1131
34. Harley CB, Futcher AB, Greider CW. 1990. Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460 (Pubitemid 20178256)
35. Hathcock KS, Hemann MT, Opperman KK, Strong MA, Greider CW, Hodes RJ. 2002. Haploinsufficiency of mTR results in defects in telomere elongation. Proc. Natl. Acad. Sci. USA 99:3591-3596
36. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, et al. 1998. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet. 19:32-38
37. Hemann MT, Rudolph KL, Strong MA, DePinho RA, Chin L, Greider CW. 2001.Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol. Biol. Cell 12:2023-2030 (Pubitemid 33049696)
38. Hemann MT, Strong MA, Hao LY, Greider CW. 2001. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107:67-77
39. Ilmonen P, Kotrschal A, Penn DJ. 2008. Telomere attrition due to infection. PLoS ONE 3:e2143
40. Knight SW, Heiss NS, Vulliamy TJ, Aalfs CM, McMahon C, et al. 1999. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br. J. Haematol. 107:335-339 (Pubitemid 29530220)
41. Knight SW, Vulliamy T, Forni GL, Oscier D, Mason PJ, Dokal I. 1996. Fine mapping of the dyskeratosis congenita locus in Xq28. J. Med. Genet. 33:993-995 (Pubitemid 27023396)
42. Knudson M, Kulkarni S, Ballas ZK, Bessler M, Goldman F. 2005. Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. Blood 105:682-688 (Pubitemid 40070753)
43. Lafontaine DL, Bousquet-Antonelli C, Henry Y, Caizergues-Ferrer M, Tollervey D. 1998. The box H + ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase. Genes Dev. 12:527-537 (Pubitemid 28101015)
44. Lawson WE, Loyd JE. 2006. The genetic approach in pulmonary fibrosis: Can it provide clues to this complex disease? Proc. Am. Thorac. Soc. 3:345-349
45. Lee HW, Blasco MA, Gottlieb GJ, Horner JW 2nd, Greider CW, DePinho RA. 1998. Essential role of mouse telomerase in highly proliferative organs. Nature 392:569-574
46. Lendvay TS, Morris DK, Sah J, Balasubramanian B, Lundblad V. 1996. Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 144:1399-1412 (Pubitemid 26427890)
47. Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR. 1997. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276:561-567 (Pubitemid 27193675)
48. Marrone A, Walne A, Tamary H, Masunari Y, Kirwan M, et al. 2007.Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. Blood 110:4198-4205
49. Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, et al. 2004. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin. Cancer Res. 10:3317-3326
50. Meeker AK, Hicks JL, Platz EA, March GE, Bennett CJ, et al. 2002. Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res. 62:6405-6409
51. Meier UT. 2005. The many facets of H/ACA ribonucleoproteins. Chromosoma 114:1-14
52. Mitchell JR, Cheng J, Collins K. 1999. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end. Mol. Cell Biol. 19:567-576 (Pubitemid 29018458)
53. Mitchell JR, Wood E, Collins K. 1999. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402:551-555
54. Mozdy AD, Cech TR. 2006. Low abundance of telomerase in yeast: implications for telomerase haploinsufficiency. Rna 12:1721-1737
55. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, et al. 1997. Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959
56. Ni J, Tien AL, Fournier MJ. 1997. Small nucleolar RNAs direct site-specific synthesis of pseudouridine in ribosomal RNA. Cell 89:565-573 (Pubitemid 27511767)
57. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, et al. 2002. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat. Genet. 32:280-284
58. Olovnikov AM. 1996. Telomeres, telomerase, and aging: origin of the theory. Exp. Gerontol. 31:443-448
59. Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK. 2007. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am. J. Respir. Crit. Care Med. 176:277-284
60. Palm W, de Lange T. 2008. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 42:301-334
61. Raghu G,Weycker D, Edelsberg J, Bradford WZ, Oster G. 2006. Incidence and prevalence of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 174:810-816 (Pubitemid 44511663)
62. Risques RA, Lai LA, Brentnall TA, Li L, Feng Z, et al. 2008. Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology 135:410-418
63. Rocha V, Devergie A, Socie G, Ribaud P, Esperou H, et al. 1998. Unusual complications after bone marrow transplantation for dyskeratosis congenita. Br. J. Haematol. 103:243-248 (Pubitemid 28470826)
64. Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL. 2007. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447:725-729 (Pubitemid 46889729)
65. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, et al. 1999. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96:701-712 (Pubitemid 29122812)
66. Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, et al. 2003. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299:259-262 (Pubitemid 36125213)
67. Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP. 2008. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am. J. Hum. Genet. 82:501-509
68. Schlessinger D, Van Zant G. 2001. Does functional depletion of stem cells drive aging? Mech. Ageing Dev. 122:1537-1553 (Pubitemid 32757131)
69. Sharpless NE, DePinho RA. 2007. How stem cells age and why this makes us grow old. Nat. Rev. Mol. Cell Biol. 8:703-713
70. Singer MS, Gottschling DE. 1994. TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science 266:404-409
71. Steele MP, Speer MC, Loyd JE, Brown KK, Herron A, et al. 2005. Clinical and pathologic features of familial interstitial pneumonia. Am. J. Respir. Crit. Care Med. 172:1146-1152 (Pubitemid 43066651)
72. Thomas AQ, Lane K, Phillips J 3rd, Prince M, Markin C, et al. 2002. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am. J. Respir. Crit. Care Med. 165:1322-1328
73. Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, et al. 2007. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl. Acad. Sci. USA 104:7552-7557 (Pubitemid 47185944)
74. Tsuji T, Aoshiba K, Nagai A. 2006. Alveolar cell senescence in patients with pulmonary emphysema. Am. J. Respir. Crit. Care Med. 174:886-893 (Pubitemid 44564788)
75. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, et al. 2005. Obesity, cigarette smoking, and telomere length in women. Lancet 366:662-664 (Pubitemid 41176019)
76. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. 1994. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA 91:9857-9860 (Pubitemid 24311907)
77. Vulliamy T, Beswick R, Kirwan M, Marrone A, Digweed M, et al. 2008. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc. Natl. Acad. Sci. USA 105:8073-8078 (Pubitemid 351904710)
78. Vulliamy T, Marrone A, Dokal I, Mason PJ. 2002. Association between aplastic anaemia and mutations in telomerase RNA. Lancet 359:2168-2170 (Pubitemid 34694028)
79. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, et al. 2001. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413:432-435 (Pubitemid 32928599)
80. Vulliamy T, Marrone A, Szydlo R,Walne A, Mason PJ, Dokal I. 2004. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat. Genet. 36:447-449 (Pubitemid 38620026)
81. Walne AJ, Dokal I. 2008. Dyskeratosis congenita: a historical perspective. Mech. Ageing Dev. 129:48-59
82. Walne AJ, Vulliamy T, Beswick R, Kirwan M, Dokal I. 2008. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood 112:3594-3600
83. Walne AJ, Vulliamy T, Marrone A, Beswick R, Kirwan M, et al. 2007. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum. Mol. Genet. 16:1619-1629 (Pubitemid 47050675)
84. Wong JM, Collins K. 2006. Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev. 20:2848-2858 (Pubitemid 44771746)
85. Wong KK, Chang S,Weiler SR, Ganesan S, Chaudhuri J, et al. 2000. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat. Genet. 26:85-88 (Pubitemid 30692863)
86. Yabe M, Yabe H, Hattori K, Morimoto T, Hinohara T, et al. 1997. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation. Bone Marrow Transplant. 19:389-392 (Pubitemid 27096073)
87. Yaghmai R, Kimyai-Asadi A, Rostamiani K, Heiss NS, Poustka A, et al. 2000. Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome. J. Pediatr. 136:390-393 (Pubitemid 30470964)
88. Yamaguchi H, Baerlocher GM, Lansdorp PM, Chanock SJ, Nunez O, et al. 2003. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 102:916-918 (Pubitemid 36917783)
89. Yamaguchi H, Calado RT, Ly H, Kajigaya S, Baerlocher GM, et al. 2005. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Engl. J. Med. 352:1413-1424 (Pubitemid 40471449)
90. Yang Y, Isaac C,Wang C, Dragon F, Pogacic V, Meier UT. 2000. Conserved composition of mammalian box H/ACA and box C/D small nucleolar ribonucleoprotein particles and their interaction with the common factor Nopp140. Mol. Biol. Cell 11:567-577 (Pubitemid 30112166)